市场调查报告书
商品编码
1261512
2022-2028 年全球光学成像市场规模,份额,行业趋势分析报告,按产品,最终用户,技术,应用,治疗领域,地区展望和预测Global Optical Imaging Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Technique, By Application, By Therapeutic Area, By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,光学成像市场规模预计将达到 31 亿美元,预测期内復合年增长率为 13.1%。
例如,拉曼光谱检查光的非弹性散射,而荧光和磷光依赖于吸收后的发射。 光学成像提供了纳米 (nm) 范围内非常高的空间分辨率的潜力,从而产生实时和定量数据。 此外,可以照亮组织并从身体深处收集发光的光纤内窥镜探头可能有助于解决这个问题。 此外,由于近红外光在软组织中的散射和吸收比可见光少,因此近红外成像可用于观察数厘米的深度。
荧光成像用于先进的荧光介导断层扫描/类似 microCT 的混合断层扫描系统,为药物研究中的传统 PET 分析提供了一种有用的替代方法。 广角 NIR 荧光分子内窥镜和其他设备设计正在推广,以促进食管病变和结直肠腺瘤的早期检测。
COVID-19 影响分析
COVID-19 大流行使保持社交距离对医生和其他医护人员来说更加重要。 由于 COVID-19,几个成像部门的光学成像病例数量正在迅速减少。 光学成像病例的减少将对所有临床环境的短期和长期经济稳定性产生严重影响。 由于 COVID-19,全球对光学成像设备的需求显着减少。 光学影像设备需求的大幅下降主要是由于疫情导致各国取消择期手术以及关闭医院和诊断机构。 预计门诊人数下降也将在整个预测期内抑制市场扩张。
市场增长因素
技术进步
生物医学工程师正在政府资助下开发一种最先进的光学成像方法,该方法可以识别巩膜中胶原纤维的结构变化。 该技术使用计算机模型将巩膜蛋白的特定改变与早发性青光眼联繫起来。 这项新测试可实现早期治疗和持续的非侵入性治疗反应监测,以保护视力。 工程师们正在开髮用于关键实时成像的光学成像设备,以检测大脑中的血流和氧气使用等代谢过程。 这支持了本地市场的增长。
覆盖面的扩大
可见光,近红外光和近紫外光的拉曼散射是拉曼光谱的基础。 物质的分子振动与激光相互作用引起能量变化,从而揭示物质的化学成分。 它用于鑑定化合物,晶体和物质的结构分析。 拉曼气体分析仪在外科手术中用于监测麻醉气体混合物。 光学成像技术在各种疾病诊断和治疗中的广泛应用有望推动光学成像市场的增长。
市场约束
医护人员短缺
卫生工作者对于卫生系统的运作至关重要。 它的可用性,可及性,可接受性和质量都是扩大医疗保健覆盖面和实现享有最大可能健康水平的权利的决定因素。 世界卫生组织预测,到 2030 年将有 1000 万卫生工作者短缺,其中大部分在低收入和中等收入国家。 所有社会经济层面的政府都在不同程度上面临培训,僱用,部署,保留和履行其劳动力的挑战。 这些因素正在推动该地区市场的扩张。
产品概览
根据产品,光学成像市场分为成像系统,相机,软件,照明系统,镜头及其他。 成像系统部分在光学成像市场占据主导地位,2021 年收入份额最大。 这是由于它在癌症,眼科和其他领域的广泛应用。 这些系统经常被使用,因为它们提供实时微米级分辨率,一维深度,二维横截面和 3D 体积图像,成像深度高达几毫米,并且没有有害辐射。
应用展望
根据应用,光学成像市场分为病理成像和术中成像。 术中成像部分在 2021 年的光学成像市场中占据了相当大的收入份额。 这是因为术中成像和监测使医生能够获得生理信息来指导手术,并从长远来看改善恢復时间和生活质量。 在这种情况下,光学成像提供了一种高度实用,便携,负担得起的实时解决方案,该解决方案对多种感兴趣的生理因素敏感。
最终用户视角
按最终用户划分,光学成像市场分为医院和诊所,研究实验室以及製药和生物技术公司。 实验室部门在 2021 年的光学成像市场中占据了显着的收入份额。 这是由于越来越重视研发工作,以创造各种光学成像的新应用。 随着越来越多的光学成像技术被用于临床前研究和药物发现程序,市场有望得到发展。 生命科学行业研发活动的增加将在预测期内进一步推动该领域的扩张。
治疗领域展望
根据治疗领域,光学成像市场分为眼科,肿瘤科,心脏病科,皮肤科,神经科等。 2021 年,肿瘤科在光学成像市场的收入份额最高。 这是因为通过使用光学方法检查组织,可以检测组织的生化和结构方面。 它还具有灵敏度高,成本低,分辨率高等优点。 该技术也越来越受欢迎,因为它有助于及早发现癌症并且是非侵入性的。 随着癌症变得越来越普遍,有助于早期癌症检测的光学成像将推动这一领域的增长飞速发展。
技术展望
根据技术,光学成像市场分为光学相干层析成像,近红外光谱,高光谱成像和光声层析成像。 在2021年的光学成像市场中,光声层析成像领域取得了令人瞩目的增长速度。 这是因为光声断层扫描是一种混合的非侵入性成像技术,可同时适应分子成像和功能成像。 此外,随着对非侵入性技术的需求不断增加,光学层析成像技术在生物医学成像方面优于传统的光学成像竞争对手。 所有这些原因预计将有助于预测期内该行业的扩张。
区域展望
按地区划分,分析了北美,欧洲,亚太地区和 LAMEA 的光学成像市场。 北美地区将在 2021 年占据光学成像市场的最高收入份额。 这是由于政府通过提供合格的人力资源,强大的研究基础设施,投资和资金来支持该领域的技术进步。 此外,该领域技术改进项目的快速采用有望进一步加速市场扩张。
市场进入者采取的主要策略是收购。 根据基数矩阵中的分析,Abbott Laboratories 和 Leica Microsystems GmbH (Danaher Corporation) 是光学成像市场的领导者。 Carl Zeiss AG 和 Canon Inc.(佳能医疗系统公司)等公司是光学成像市场的主要创新者。
The Global Optical Imaging Market size is expected to reach $3.1 billion by 2028, rising at a market growth of 13.1% CAGR during the forecast period.
Optical imaging technologies have great potential for the healthcare sector in terms of improving illness detection, prevention, and treatment. Due to factors such as emerging application areas, increased consumer demand for noninvasive technologies, and an increase in chronic diseases and eye conditions, the market for optical imaging systems is growing. Due to the growing emphasis on early illness diagnosis and the desire for efficient solutions, optical imaging system sales are anticipated to rise quickly.
The science of optical imaging, which employs light to examine cellular and molecular activity in live organisms, is non-invasive and non-ionizing. Electromagnetic radiation, including visible light, contains wave and particle characteristics. Depending on the makeup of the tissue, photons may be absorbed, reflected, or dispersed as they pass through it. Various optical imaging techniques examine these interactions to produce distinctive spectral fingerprints that might provide information about the molecular structure of the target tissue.
For instance, Raman spectroscopy examines the inelastic scattering of light, whereas fluorescence and phosphorescence rely on the emission of light after its absorption. Optical imaging offers a very high spatial resolution in the nanometre (nm) range and may give real-time and quantitative data. Fiberoptic endoscopic probes, which enable tissue lighting and collecting the emitted light from deep inside the body, may partially help overcome this. Moreover, soft tissues exhibit less scattering and absorption in the electromagnetic spectrum's near-infrared (NIR) region than in the visible band, allowing the probing depth to be raised to a few centimeters when utilizing NIR optical imaging.
Fluorescence imaging is used in hybrid tomographic systems like advanced fluorescence-mediated tomography/micro-CT, which provides a useful alternative to traditional PET analysis in drug research. Wide-field NIR fluorescence molecular endoscopy and other device designs have been promoted for enhancing the early detection of esophageal lesions and colorectal adenomas.
COVID-19 Impact Analysis
The COVID-19 pandemic made it more important for physicians and other healthcare workers to maintain social distancing. Due to COVID-19, optical imaging case volumes have rapidly decreased in several imaging and diagnostic departments. The fall in optical imaging cases seriously impacts the short- and long-term economic stability of all practice settings. The need for optical imaging devices has significantly decreased globally because of COVID-19. The large drop in demand for optical imaging equipment is primarily attributable to canceling of elective operations and the closing of hospitals and diagnostic facilities in various nations due to the pandemic. Also, the decline in outpatient visits is anticipated to restrain market expansion throughout the projection period.
Market Growth Factors
Technological progress
A cutting-edge optical imaging method that can identify changes in the organization of the collagen fibers in the eye sclera is being developed by biomedical engineers with funding from the government. The technique uses a computer model that links certain alterations in sclera proteins to early-onset glaucoma. The new test will allow for early treatment that preserves eyesight and ongoing non-invasive treatment response monitoring. Engineers are developing an optical imaging device for crucial real-time imaging that detects brain blood flow and metabolic processes, including oxygen use. This supports the growth of the regional market.
Expanding the spheres of applicability
Raman scattering of visible, near-infrared, or near-ultraviolet light provides the basis for Raman spectroscopy. The material's molecular vibrations interact with the laser light, causing energy changes that disclose the substance's chemical composition. Uses include the identification of chemical compounds and the crystal and material structure. Raman gas analyzers are used in surgery to monitor the anesthetic gas mixture. The wide usage of optical imaging techniques for diagnosing and treating various diseases is expected to boost the optical imaging market growth.
Market Restraining Factors
Lack of healthcare workers
Health workers are essential to the operation of health systems. Their availability, accessibility, acceptability, and quality are all determinants of expanding healthcare coverage and attaining the right to the enjoyment of the greatest possible level of health. By 2030, the WHO predicts a ten-million-person shortage in the health workforce, mostly in low- and lower-middle-income nations. To varied degrees, governments at all socioeconomic levels have challenges with their workforce's training, employment, deployment, retention, and performance. These elements are assisting the market's expansion in the region.
Product Outlook
Based on product, the optical imaging market is segmented into imaging systems, camera, software, illuminating systems and lenses & others. The imaging systems segment dominated the optical imaging market with maximum revenue share in in 2021. This is due to its extensive use in cancer, ophthalmology, and other fields. These systems are frequently used because they provide real-time, micron-level resolution, 1D depth, 2D cross-sectional, and 3D volumetric pictures at imaging depths of up to a few millimeters and no harmful radiation.
Application Outlook
On the basis of application, the optical imaging market is divided into pathological imaging and intraoperative imaging. The intraoperative imaging segment garnered a substantial revenue share in the optical imaging market in 2021. This is owing to intraoperative imaging and monitoring, which gives doctors access to physiological information that may be used to guide surgery and enhance recovery time and quality of life in the long run. Optical imaging in this context provides extremely practical, portable, affordable, and real-time solutions sensitive to several physiological factors of interest.
End User Outlook
By end user, the optical imaging market is classified into hospitals & clinics, research laboratories and pharmaceutical & biotechnology companies. The research laboratories segment recorded a prominent revenue share in the optical imaging market in 2021. This is due to the increased emphasis on R&D operations to create different new applications of optical imaging. The market is expected to develop as more optical imaging techniques are used in preclinical research and drug discovery procedures. The increasing R&D efforts in the life sciences industry will further boost the segment's expansion in the forecasted period.
Therapeutic Area Outlook
Based on the therapeutic area, the optical imaging market is bifurcated into ophthalmology, oncology, cardiology, dermatology, neurology and others. The oncology segment registered the highest revenue share in the optical imaging market in 2021. This is because the optical way of examining tissues can detect both the biochemical and structural aspects of the tissue. It also has the benefits of high sensitivity, low cost, and high resolution. The technique is also gaining popularity since it aids in the early identification of cancer and is non-invasive. As cancer is becoming more common, along with the benefits optical imaging provides in early cancer detection, the segment's growth will surge.
Technique Outlook
On the basis of technique, the optical imaging market is divided into optical coherence tomography, near infrared spectroscopy, hyperspectral imaging and photoacoustic tomography. The photoacoustic tomography segment garnered a remarkable growth rate in the optical imaging market in 2021. This is because photoacoustic tomography is a hybrid noninvasive imaging technique for both molecular and functional imaging. In addition, the demand for noninvasive technology is growing, and optical tomography performs better in biomedical imaging than its traditional optical imaging competitors. All these reasons are anticipated to contribute to the segment's expansion in the projected period.
Regional Outlook
Region-wise, the optical imaging market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the optical imaging market in 2021. This is due to the availability of qualified people, a strong research infrastructure, and government attempts to support technical improvement in the sector by providing investments and money. Moreover, quicker adoption of technologically improved items in the area is anticipated to accelerate market expansion further.
The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Abbott Laboratories and Leica Microsystems GmbH (Danaher Corporation) are the forerunners in the Optical Imaging Market. Companies such as Carl Zeiss AG and Canon, Inc. (Canon Medical Systems Corporation) are some of the key innovators in Optical Imaging Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss AG, Leica Microsystems GmbH (Danaher Corporation), Abbott Laboratories, Canon, Inc. (Canon Medical Systems Corporation), PerkinElmer, Inc., Topcon Corporation, Hamamatsu Photonics K.K., Koninklijke Philips N.V., Heidelberg Engineering, Inc. and Visionix Ltd.
Recent Strategies Deployed in Optical Imaging Market
Partnerships, Collaborations and Agreements:
Jan-2023: Canon came into partnership with ScImage, Inc., a Cloud-native image management company offering services to the healthcare industry. This partnership would enable Canon to leverage Sclmage cloud-driven image management and PACS solutions in enhancing Canon's outreach in hemodynamics empowering it to better serve its customers.
May-2022: Visionix partnered with Right MFG. Co., Ltd., an innovative medical devices manufacturer, for making growth in their businesses. With this partnership, Right MFG's expertise in offering advanced medical devices would enable Visionix to develop and deliver a product range for eyecare businesses facilitating eye care professionals.
Mar-2022: Hamamatsu Photonics K.K announced its collaboration with Proscia, a digital and computational pathology solutions provider, to enhance digital pathology embracement. Through this partnership, Hamamatsu's NanoZoomer® series of whole slide scanners for digital transformation would be combined with Proscia's Concentriq® platform to create an open ecosystem for raising the digital pathology embracement ratio in the market.
Aug-2020: Canon signed a partnership with Zebra Medical Vision, a computer vision startup serving healthcare, to broaden its AI offerings. With this partnership, Zebra Medical Vision's services into the Modality domain would empower Canon to deliver its AI1™ automated imaging analysis solutions to facilitate U.S. clinicians in the delivery of faster, and required diagnoses to patients.
Product Launches and Product Expansions:
Nov-2021: Koninklijke Philips N.V. unveiled AI-based MR suite of smart diagnostic systems. The MR portfolio would incorporate smart integrated solutions such as MR 7700 3.0T system, developed to accelerate MR examination, smooth workflow, improved diagnostic quality, and provide aid in the optimization of radiology operations.
Jul-2021: Canon announced the launch of Xephilio OCT-S1, an advanced Wide -field Swept Source Optical Coherence Tomography. Xephilio OCT-S1 would enable customers to capture high-resolution pictures of up to 23 x 20 mm in just one-time scanning. Additionally, it would allow users to use its wide-angle OCT Imaging Angiography feature and delivers OCTA images with enhanced visibility.
Apr-2021: Abbott unveiled an AI-powered coronary OCT imaging system in Europe. The AI-powered coronary OCT imaging system, developed by integrating imaging technology with AI and would offer surgeons an automated system useful in cardiac procedures, providing information quickly in the course of the placement of coronary stents.
Acquisitions and Mergers:
Jan-2023: Carl Zeiss completed the acquisition of Lenso, an optical 3D metrology manufacturer, to make developments in Zeiss's Industrial Quality and Research division. Through this acquisition, Carl Zeiss's industrial quality solutions would be utilized for Zeiss's Industrial Quality & Research division expansion across Poland.
Oct-2022: Carl Zeiss acquired GOM Metrology, to serve the UK customer base by providing better tactile and optical technology suite offerings. With this acquisition, GOM Metrology would bring its GOM software, machines, automated 3D coordinate computing technology, and 3D testing to strengthen Zeiss Industrial Quality Solutions' portfolio.
Oct-2021: Carl Zeiss took over Capture 3D, a 3D Scanning technology, photogrammetry, and automated inspection solutions provider, to make advancements in optical digitization systems. Through this acquisition, Capture 3D's capabilities in supplying required data intelligence for better decision-making would enable Zeiss to better support its customers by providing them the advanced measurement solutions.
Oct-2021: Canon acquired Redlen Technologies, developer and manufacturer of high-resolution CZT semiconductor detectors. Through this acquisition, Canon would make developments in its medical systems business by getting advanced radiation detection and imaging technology, utilized in CZT semiconductor detector modules, through Redlen Technologies to develop advanced PCCT systems.
Jul-2021: Topcon Corporation completed the acquisition of VISIA Imaging S.r.l, an Italian-based ophthalmic device manufacturing company. Through this acquisition, VISIA's expertise in manufacturing anterior segment evaluation hardware and software would be leveraged by Topcon to intensify Topcon's manufacturing and innovation capabilities in anterior segment devices and software that would advance Topcon's fundus imaging devices suite.
Market Segments covered in the Report:
By Product
By End User
By Technique
By Application
By Therapeutic Area
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures